Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 16, 2022 09:30 ET | Source: Hatch

Hatch Announces Its First Board of Experts to Drive Awareness Around the Impact of Sleep on Overall Health and Wellness

PALO ALTO, Calif., June 16, 2022 (GLOBE NEWSWIRE) -- Hatch, a sleep industry leader, today introduced the Board of Experts, a first of its kind composed of specialists across health industries,...
June 10, 2022 15:05 ET | Source: Arizton Advisory and Intelligence

The U.S. Digital Therapeutics Market is Expected to Reach $8.8 Billion by 2027 - Arizton

Chicago, June 10, 2022 (GLOBE NEWSWIRE) -- According to Arizton’s latest research report, the U.S. digital therapeutics market is expected to grow at a CAGR of 33.15% during 2022-2027. The digital...
June 08, 2022 10:00 ET | Source: Sermonix Pharmaceuticals Inc.

Sermonix Pharmaceuticals’ Phase 2 Lasofoxifene Trial Poster Receives a GRASP Advocate Choice Award, Selected for Post-ASCO Patient Advocate Investigator Discussions

Guiding Researchers and Advocates to Scientific Partnerships (GRASP) launched in 2019 to unite patient advocates, physicians and researchers through meaningful discussions of cancer-related...
June 06, 2022 16:27 ET | Source: HTG Molecular Diagnostics, Inc.

HTG Technology Featured in Multiple Scientific Abstracts Highlighting Novel Applications in Precision Medicine at ASCO 2022

TUCSON, Ariz., June 06, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide...
June 06, 2022 16:15 ET | Source: Delcath Systems, Inc.

Positive Initial Results from CHOPIN Phase 1b Trial, FOCUS Trial Update and QoL Study Presented at the 2022 ASCO Annual Meeting

Initial results from the Phase 1b portion of the CHOPIN trial of PHP in combination with ipilimumab plus nivolumab in advanced uveal melanoma in seven patients resulted in 85.7% Best Overall Response...
June 01, 2022 10:00 ET | Source: BetterVet

As In-Home and Virtual Veterinary Care Demands Increase, BetterVet® Answers the Call With Expansion Into Dallas and Baltimore

Boston, MA, June 01, 2022 (GLOBE NEWSWIRE) -- BetterVet®, providers of world-class mobile and virtual veterinary care, today announced expansion into two major US markets, Dallas and Baltimore,...
May 31, 2022 15:25 ET | Source: Sermonix Pharmaceuticals Inc.

Sermonix to Present Updated Data from ELAINE-2 Clinical Trial of Lasofoxifene in Combination with Abemaciclib in Women with Locally Advanced or Metastatic ER+/HER2− Breast Cancer and an ESR1 Mutation after Progression on Prior Therapies at the 2022 ASCO Annual Meeting

COLUMBUS, Ohio, May 31, 2022 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat ESR1-mutated...
May 31, 2022 08:00 ET | Source: Zai Lab Limited

Zai Lab to Present New PRIME Subgroup Analysis for Niraparib in Ovarian Cancer at 2022 ASCO Annual Conference

Presentation features a new subgroup analysis of the Phase 3 PRIME study exploring the efficacy of niraparib maintenance therapy for patients in China with advanced ovarian cancer based on their...
May 26, 2022 17:00 ET | Source: Adagene Inc.

Adagene Announces Publication at ASCO of Interim Monotherapy Dose Escalation Data Showing Compelling Safety Profile of Anti-CTLA-4 SAFEbody® ADG126, with Repeat Dosing Across Dose Levels

- First clinical data demonstrating potential of SAFEbody technology platform to create best-in-class therapeutics - - Additional data from ongoing ADG126 clinical program to be...
May 23, 2022 10:00 ET | Source: University of Minnesota Medical School

U of M receives NIAID grant to develop drug treatments for future viral pandemics

MINNEAPOLIS/ST. PAUL, May 23, 2022 (GLOBE NEWSWIRE) -- The University of Minnesota has received $66 million from the National Institute of Allergy and Infectious Diseases (NIAID) to establish a...